Skin boosters for the periorbital area: indication and risks

There are few areas of the face where the difference between a good result and a serious complication is as narrow as around the eyes. Eyelid skin is the thinnest in the body, swelling comes easily, the Tyndall effect is frequent, and the vascularity connects with the eye's circulation. At the same time, it is one of the most common concerns: "tired look," "thin skin," "lines under the eyes." The skin booster is one of the options discussed, and it deserves an especially careful look.

This page gathers the indication, risks, and limits of the skin booster in the periorbital area, at a review level. It does not describe injection technique, depth, or volumes. The decision rests with the licensed professional, according to the rules of their professional council in Brazil and the product's instructions for use.

What makes the periorbital area different?

Four characteristics explain the caution.

1. Very thin skin. With little dermis and little fat, any superficial product can show or be noticed.
2. Fragile drainage. The tissue is loose and accumulates fluid; swelling is frequent and can be persistent. See chronic eyelid swelling after filler.
3. Delicate supporting structures. The orbicular retaining ligament, the tear trough, and the fat pads define the contour of the area.
4. Circulation tied to the eye. Branches of the ophthalmic artery, such as the supraorbital and supratrochlear, connect with the circulation of the face. An intravascular injection can lead to ocular complications; see visual complication after filler.

For the anatomy applied to the area, the complementary reading is the page periorbital anatomy for injectables.

Who may benefit?

The profile that fits best is thin, dehydrated skin with fine lines, with no dominant volume concern. Some situations in which the skin booster is usually considered:

• A thin, "tissue paper" look on the lower eyelid.
• Fine lines under the eyes, without significant bags.
• Visible dehydration of the area.
• A complement to other treatments, in individualized protocols.

In cases of an obvious tear trough depression, fat bags, or significant pigmentation, the skin booster probably does not solve the concern. The differentiation of the type of dark circle is in dark circles: types and assessment, and the comparison with the specific procedure is in skin boosters for under-eye areas.

What are the most important risks?

The table summarizes, at a review level, the risks specific to the area, in addition to the general ones described in skin booster complications.

How do you assess and plan?

The assessment should be more detailed than in lower-risk areas.

Planning should consider whether this is the best moment: postpone in case of infection, significant swelling, or recent use of substances that increase bleeding. The pages anticoagulants and injectable procedures and supplements and bruising risk cover this.

And if the concern is something else?

If the patient expects to "lift the look," "remove bags," or "erase dark circles," the skin booster is not the answer. For tear trough volume, filler is the option discussed in hyaluronic acid for under-eye areas. For bags, the assessment may involve surgery, as explained in malar bags: assessment. For pigment, management is dermatological; see infraorbital hyperpigmentation after a procedure.

What should you advise and how do you talk about it?

The patient needs to understand that the periorbital area is one of the most sensitive, that the result is subtle, and that there is a risk of prolonged swelling. Also explain the warning signs and what to do.

Reinforce that a "dark circle that disappears" should not be expected. Comparison with the before photo, under the same light, is what shows the change honestly. The text on explaining dark circles to the patient helps structure the conversation.

When to postpone or refer

Consider postponing or not doing it in situations such as local infection or inflammation, pronounced dry eye, chronic swelling, allergy to hyaluronic acid, unrealistic expectations, or inability to follow up. Refer to ophthalmology for any eye complaint, and to dermatology if there is a relevant skin disease. The flow is in patient referral in facial harmonization.

How do you handle swelling that won't go away?

Around the eyes, swelling is the most common reason for an unhappy return visit. When it persists longer than expected, three questions are worth asking: is the product too superficial and retaining water, does the patient have a prior tendency toward eyelid swelling (from allergy, sleep, salt, reflux, or thyroid disease), or is an inflammatory reaction under way? The answer changes the management, which may be just observing, reviewing habits, considering hyaluronidase, or referring for clinical assessment.

Record the course with photos under the same light and avoid deciding to dissolve in the first few weeks, when the area is still settling. Agree with the patient on when the reassessment will be and which signs call for contact sooner: pain, warmth, spreading redness, or any visual change. This clarity reduces anxiety and protects the relationship with the patient, even when the result takes time to settle.

How Harmy fits in

In Harmy, the Tear Trough area lets you plan volume in the tear trough, which is a different approach from the skin booster. It helps show the patient the effect of filler in that area and makes it clear that skin hydration is something else.

Key takeaways

In the periorbital area, the skin booster is an option for thin skin, with a subtle effect and a higher risk than in other areas. Define the type of dark circle, assess the eye and the history, align expectations about swelling and Tyndall, document the consent, keep hyaluronidase and the emergency plan at hand, and know when to postpone or refer.